Company Performance: GAUZ.US stock price is heavily influenced by Geron Corporation's financial health, including revenue, earnings, and profit margins.

Clinical Trial Results: Positive or negative data from clinical trials of Geron's drug imetelstat significantly impacts investor sentiment and stock valuation.

Regulatory Approvals: FDA decisions regarding imetelstat's approval for specific indications drive substantial price movements.

Market Conditions: Overall market trends, investor confidence, and sector-specific performance in biotechnology affect GAUZ.US.

Competition: News and advancements from competing companies in the myelodysplastic syndromes (MDS) and myelofibrosis fields can influence investor perception.

Partnerships & Funding: Strategic alliances, collaborations, or successful fundraising activities may boost investor confidence.

Economic Factors: Macroeconomic conditions such as interest rates and inflation can affect investor risk appetite and investment decisions in GAUZ.US.

News & Events: General news about Geron, industry updates, and major events can cause short-term price volatility.